BB Biotech AG
BION
Clasificación en acciones
#4507
BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG.... BB Biotech AG is an investment fund overseen by Bellevue Asset Management AG. This fund allocates capital to publicly traded companies worldwide, with a primary focus on firms pioneering modern biotechnology, specifically in the development of medications and diagnostic tools. The construction of its investment portfolio is guided by a fundamental analysis approach. Established on November 9, 1993, BB Biotech AG is headquartered in Switzerland.
Precio por acción
$61.40
Última sincronización: 2026-10-21
Capitalización bursátil
$3.39B
Cambio (1 día)
-5.95%
Cambio (1 año)
25.48%
País
CH
Comercio BB Biotech AG (BION)
Categoría
Financial Services
Ganancias de BB Biotech AG (BION)
Ganancias en 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di BB Biotech AG, gli utili attuali della società sono 0. Nel 2026, la società ha registrato un utile di 0, igual a agli utili del 2026, che erano di 0. Gli utili mostrati in questa pagina sono quelli prima degli interessi e delle imposte, ovvero EBIT.
Historial de ganancias de BB Biotech AG desde 2026 hasta 2026
Ganancias al final de cada año
| Año | Ganancias | Cambiar |
|---|---|---|
| Not enough data for the provided dates. | ||
Ganancias de empresas similares o competidoras
| Empresa | Ganancias | Diferencia de ganancias | País |
|---|---|---|---|
| $9.81B | - |
US
|
|
| - | - |
SE
|
|
| $8.07B | - |
US
|
|
| $6.64B | - |
US
|
|
| $3.70B | - |
US
|
